JP2013046616A5 - - Google Patents

Download PDF

Info

Publication number
JP2013046616A5
JP2013046616A5 JP2012202508A JP2012202508A JP2013046616A5 JP 2013046616 A5 JP2013046616 A5 JP 2013046616A5 JP 2012202508 A JP2012202508 A JP 2012202508A JP 2012202508 A JP2012202508 A JP 2012202508A JP 2013046616 A5 JP2013046616 A5 JP 2013046616A5
Authority
JP
Japan
Prior art keywords
base sequence
seq
sequence represented
rna strand
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012202508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013046616A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012202508A priority Critical patent/JP2013046616A/ja
Priority claimed from JP2012202508A external-priority patent/JP2013046616A/ja
Publication of JP2013046616A publication Critical patent/JP2013046616A/ja
Publication of JP2013046616A5 publication Critical patent/JP2013046616A5/ja
Pending legal-status Critical Current

Links

JP2012202508A 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法 Pending JP2013046616A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012202508A JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2010158193 2010-07-12
JP2010158193 2010-07-12
JP2010158192 2010-07-12
JP2010158194 2010-07-12
JP2010158192 2010-07-12
JP2010158194 2010-07-12
JP2012202508A JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011530188A Division JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Publications (2)

Publication Number Publication Date
JP2013046616A JP2013046616A (ja) 2013-03-07
JP2013046616A5 true JP2013046616A5 (enExample) 2014-08-14

Family

ID=45469308

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2012202508A Pending JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2012202509A Pending JP2013034479A (ja) 2010-07-12 2012-09-14 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012202509A Pending JP2013034479A (ja) 2010-07-12 2012-09-14 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Country Status (5)

Country Link
US (2) US9476041B2 (enExample)
EP (2) EP2594644B1 (enExample)
JP (5) JP5099571B2 (enExample)
CN (2) CN103097535A (enExample)
WO (2) WO2012008301A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103097535A (zh) 2010-07-12 2013-05-08 国立大学法人鸟取大学 利用miRNA导入的新型hiPSC制作法
WO2012126013A2 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
CA2852244C (en) 2011-10-17 2023-10-17 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
US10034902B2 (en) * 2012-02-22 2018-07-31 Exostem Biotec Ltd. MicroRNAs for the generation of astrocytes
JP6748430B2 (ja) * 2012-07-13 2020-09-02 ミネルバ バイオテクノロジーズ コーポレーション より未分化状態への細胞の誘導方法
JPWO2015030149A1 (ja) * 2013-08-29 2017-03-02 国立大学法人鳥取大学 細胞のアンチエイジングに関連する生体分子群
US20160289678A1 (en) * 2013-11-22 2016-10-06 Dcb-Usa Llc Use of microrna 146-a in the diagnosis, treatment and prevention of picornavirus infection and microrna 146-a antagonists
CN104109670B (zh) * 2014-03-12 2018-01-05 首都医科大学附属北京安定医院 一种双链siRNA分子及其应用
EA031135B1 (ru) 2014-06-27 2018-11-30 Ризен Фармасьютикалз Са Замещенные производные хромена как селективные двойные ингибиторы протеинкиназ pi3 дельта и гамма
EP3286335B1 (en) * 2015-04-24 2026-01-21 The Johns Hopkins University Methods related to characterizing proviral reservoirs
US20180311270A1 (en) * 2015-10-30 2018-11-01 Norimasa Miura Rna molecule for repairing dna damage
KR102011336B1 (ko) * 2015-12-31 2019-08-16 인터올리고 주식회사 약물 전달 및 안정화를 위한 복합체 및 그 제조방법
WO2018203553A1 (ja) * 2017-05-02 2018-11-08 株式会社ペジィー・ファーマ 分化細胞の品質改善方法
EP4423280A4 (en) * 2021-12-29 2025-12-31 Livius Pte Ltd METHOD FOR REPAIRING GENES RELATED TO A HAIR CYCLE AND METHOD FOR TREATING DISEASES RELATED TO A HAIR CYCLE USING MIR-520D-5P
JP2023149907A (ja) * 2022-03-31 2023-10-16 株式会社島津製作所 微生物情報の提供方法および微生物検査システム

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4294482B2 (ja) * 2001-11-15 2009-07-15 協和発酵キリン株式会社 胚性幹細胞から外胚葉系細胞への分化誘導剤、その取得方法及びその用途
US8609831B2 (en) 2002-09-16 2013-12-17 University Of Southern California RNA-mediated gene modulation
US20060247193A1 (en) 2003-02-10 2006-11-02 National Institute Of Advanced Industrial Science And Technology Regulation of gene expression by dna interference
US9453219B2 (en) * 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
ES2534304T3 (es) * 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
EP1848749B1 (en) 2005-02-04 2018-10-31 Auburn University Contact drug delivery system
EP2098593B1 (en) 2005-04-15 2011-12-28 National University Corporation Tottori University hTERT expression regulatory gene
SG162726A1 (en) 2005-05-27 2010-07-29 San Raffaele Centro Fond Gene vector comprising mi-rna
WO2006137514A1 (ja) 2005-06-23 2006-12-28 Locomogene, Inc. シノビオリンの発現もしくは機能阻害物質を有効成分とする癌治療剤、および癌治療剤のスクリーニング方法
CN101356270B (zh) 2005-12-13 2014-02-12 国立大学法人京都大学 核重新编程因子
EP2487261B1 (en) 2006-01-05 2015-07-01 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
ES2715625T3 (es) 2006-04-03 2019-06-05 Roche Innovation Ct Copenhagen As Composición farmacéutica que comprende oligonucleótidos antisentido anti-miARN
CN101980712B (zh) * 2007-10-29 2015-02-18 雷古拉斯治疗公司 用于肝癌治疗的靶向微小rna
EP2096169B1 (en) * 2007-10-31 2020-11-18 Kyoto University Nuclear reprogramming method
AU2008286249B2 (en) 2007-12-10 2013-10-10 Kyoto University Efficient method for nuclear reprogramming
EP2238251B1 (en) * 2007-12-27 2015-02-11 Protiva Biotherapeutics Inc. Silencing of polo-like kinase expression using interfering rna
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
CN101333524B (zh) * 2008-06-25 2010-06-02 中山大学 一个小分子非编码RNA基因hsa-miR-101及其抗肿瘤用途
CN101392251B (zh) * 2008-11-03 2015-07-22 清华大学深圳研究生院 能诱导干细胞向成骨细胞分化的微小rna及其应用
JP2010120881A (ja) * 2008-11-19 2010-06-03 Keio Gijuku ヒト癌タンパク質ＭＤＭ２とヒト癌抑制タンパク質ｐ５３との相互作用阻害ペプチド及びその使用
CN103097535A (zh) 2010-07-12 2013-05-08 国立大学法人鸟取大学 利用miRNA导入的新型hiPSC制作法

Similar Documents

Publication Publication Date Title
JP2013046616A5 (enExample)
MX2024001138A (es) Arn guia modificados.
ZA201902226B (en) Aav treatment of huntington's disease
JP2013034479A5 (enExample)
WO2014016817A3 (en) Nucleic acids for down-regulation of gene expression
WO2016183438A8 (en) Self-targeting genome editing system
MX2016007980A (es) Acido nucleico que induce acido ribonucleico de interferencia modificado para prevenir una falla en alcanzar el objetivo, y uso del mismo.
EP3372685A3 (en) Cell lines for virus production and methods of use
WO2016106401A3 (en) Rna agents for p21 gene modulation
WO2010014857A3 (en) Chromosome therapy
MX2018010529A (es) Composiciones y metodos para la produccion y administracion de acido ribonucleico.
AR100560A1 (es) Inhibición o regulación por disminución de la glucógeno sintasa mediante la creación de codones de terminación prematuros utilizando oligonucléotidos antisentido
WO2016061232A3 (en) Multiplexed shrnas and uses thereof
WO2010017436A3 (en) Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides
NZ630914A (en) Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
ES2623454T3 (es) Reducción del contenido de ácidos grasos saturados en semillas de plantas
IN2014CN03921A (enExample)
WO2010017154A3 (en) Modulation of toll-like receptor 3 expression by antisense oligonucleotides
NZ741841A (en) Antisense oligonucleotides for use in treating alzheimer’s disease
EA201690232A1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения
MX2015012063A (es) Oligonucleotidos antisentido para el tratamiento de celulas madre del cancer.
JP2012085645A5 (enExample)
JP2010270119A5 (enExample)
WO2015020993A3 (en) RNAi COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA
WO2015153880A3 (en) Modulation of hotair and adipogenesis